Login to Your Account

Pegylated Interferon, I Wish I Could Quit You

At AASLD, Keeping Ahead of A 'Wave' of New Treatments

By Anette Breindl

Wednesday, October 5, 2011
It is, of course, no great feat to predict that hepatitis C will be an important topic at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place in San Francisco in early November. The Centers for Disease Control and Prevention estimated that nearly 3 million Americans are infected with hepatitis C, meaning that the virus is rivaled only by alcoholic liver disease as a cause of liver problems.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription